Investigation of complement component C4 copy number variation in human longevity. 2014

Friederike Flachsbart, and Amke Caliebe, and Femke-Anouska Heinsen, and Tom Hemming-Karlsen, and Stefan Schreiber, and Andre Franke, and Almut Nebel
Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel, Germany.

Genetic factors have been estimated to account for about 25% of the variation in an adult's life span. The complement component C4 with the isotypes C4A and C4B is an effector protein of the immune system, and differences in the overall C4 copy number or gene size (long C4L; short C4S) may influence the strength of the immune response and disease susceptibilities. Previously, an association between C4B copy number and life span was reported for Hungarians and Icelanders, where the C4B*Q0 genotype, which is defined by C4B gene deficiency, showed a decrease in frequency with age. Additionally, one of the studies indicated that a low C4B copy number might be a genetic trait that is manifested only in the presence of the environmental risk factor "smoking". These observations prompted us to investigate the role of the C4 alleles in our large German longevity sample (∼ 700 cases; 94-110 years and ∼ 900 younger controls). No significant differences in the number of C4A, C4B and C4S were detected. Besides, the C4B*Q0 carrier state did not decrease with age, irrespective of smoking as an interacting variable. However, for C4L*Q0 a significantly different carrier frequency was observed in the cases compared with controls (cases: 5.08%; controls: 9.12%; p = 0.003). In a replication sample of 714 German cases (91-108 years) and 890 controls this result was not replicated (p = 0.14) although a similar trend of decreased C4L*Q0 carrier frequency in cases was visible (cases: 7.84%; controls: 10.00%).

UI MeSH Term Description Entries
D008136 Longevity The normal length of time of an organism's life. Length of Life,Life Span,Lifespan,Life Spans,Lifespans
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003181 Complement C4 A glycoprotein that is important in the activation of CLASSICAL COMPLEMENT PATHWAY. C4 is cleaved by the activated COMPLEMENT C1S into COMPLEMENT C4A and COMPLEMENT C4B. C4 Complement,C4 Complement Component,Complement 4,Complement C4, Precursor,Complement Component 4,Pro-C4,Pro-complement 4,C4, Complement,Complement Component, C4,Complement, C4,Component 4, Complement,Component, C4 Complement,Pro C4,Pro complement 4
D005260 Female Females
D005787 Gene Frequency The proportion of one particular in the total of all ALLELES for one genetic locus in a breeding POPULATION. Allele Frequency,Genetic Equilibrium,Equilibrium, Genetic,Allele Frequencies,Frequencies, Allele,Frequencies, Gene,Frequency, Allele,Frequency, Gene,Gene Frequencies
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D005858 Germany A country in central Europe, bordering the Baltic Sea and the North Sea, between the Netherlands and Poland, south of Denmark. The capital is Berlin.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Friederike Flachsbart, and Amke Caliebe, and Femke-Anouska Heinsen, and Tom Hemming-Karlsen, and Stefan Schreiber, and Andre Franke, and Almut Nebel
September 2011, Journal of biomedical science,
Friederike Flachsbart, and Amke Caliebe, and Femke-Anouska Heinsen, and Tom Hemming-Karlsen, and Stefan Schreiber, and Andre Franke, and Almut Nebel
January 2012, Methods in molecular biology (Clifton, N.J.),
Friederike Flachsbart, and Amke Caliebe, and Femke-Anouska Heinsen, and Tom Hemming-Karlsen, and Stefan Schreiber, and Andre Franke, and Almut Nebel
March 2016, Inflammatory bowel diseases,
Friederike Flachsbart, and Amke Caliebe, and Femke-Anouska Heinsen, and Tom Hemming-Karlsen, and Stefan Schreiber, and Andre Franke, and Almut Nebel
August 2020, International journal of molecular sciences,
Friederike Flachsbart, and Amke Caliebe, and Femke-Anouska Heinsen, and Tom Hemming-Karlsen, and Stefan Schreiber, and Andre Franke, and Almut Nebel
June 2007, American journal of human genetics,
Friederike Flachsbart, and Amke Caliebe, and Femke-Anouska Heinsen, and Tom Hemming-Karlsen, and Stefan Schreiber, and Andre Franke, and Almut Nebel
January 1985, Immunogenetics,
Friederike Flachsbart, and Amke Caliebe, and Femke-Anouska Heinsen, and Tom Hemming-Karlsen, and Stefan Schreiber, and Andre Franke, and Almut Nebel
May 1994, Biochemical Society transactions,
Friederike Flachsbart, and Amke Caliebe, and Femke-Anouska Heinsen, and Tom Hemming-Karlsen, and Stefan Schreiber, and Andre Franke, and Almut Nebel
January 1990, Experimental and clinical immunogenetics,
Friederike Flachsbart, and Amke Caliebe, and Femke-Anouska Heinsen, and Tom Hemming-Karlsen, and Stefan Schreiber, and Andre Franke, and Almut Nebel
January 2008, Cytogenetic and genome research,
Friederike Flachsbart, and Amke Caliebe, and Femke-Anouska Heinsen, and Tom Hemming-Karlsen, and Stefan Schreiber, and Andre Franke, and Almut Nebel
July 2010, Human mutation,
Copied contents to your clipboard!